Placing purines in precision medicine: Targeting a metabolic reliance in KRAS-mutant tumors将嘌呤应用于精准医学:靶向KRAS突变肿瘤的代谢依赖性iScienceIF4.12026-02-010OAAI
Acquired NF2 mutation confers resistance to TRK inhibition in an ex vivo LMNA::NTRK1-rearranged soft-tissue sarcoma cell modelJOURNAL OF PATHOLOGYIF5.22024-04-121OA
Ex vivo modeling of acquired drug resistance in BRAF - mutated pancreatic cancer organoids uncovers individual therapeutic vulnerabilitiesCANCER LETTERSIF10.12024-03-011OA
Establishment and functional testing of a novel ex vivo extraskeletal osteosarcoma cell model (USZ20-ESOS1)HUMAN CELLIF3.12023-11-111OAAI
Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma揭开软组织和骨肉瘤的同源重组修复缺陷和治疗机会EMBO MOLECULAR MEDICINEIF8.32023-02-138OAAI
De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancerONCOGENEIF7.32022-01-265OAAI